Search

everythinglearnresearchcommunity

for

Search:↓

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

Calcium channels are vital for normal skin function and their dysfunction can lead to skin issues.

Overexpressing ornithine decarboxylase and v-Ha-ras in keratinocytes leads to invasiveness and malignancy.

The most common PCOS type in adolescents is hyperandrogenic with polycystic ovaries.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

19.5% of young college girls have PCOS, highlighting the need for early screening and intervention.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Increased ornithine decarboxylase makes normally tumor-resistant mice more sensitive to tumors.

Alopecia is rare after organ transplants but more common in females, Hispanic patients, and pancreas recipients.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Auriculotherapy and Aslagh capsules are as effective as metformin for treating PCOS symptoms, with auriculotherapy slightly better for reducing hair growth.

PCOS women with COVID-19 have higher cardiometabolic risks.

Most adverse reactions to the treatment were mild, with nausea being the most common.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

MK-5108 is safe and shows potential against tumors, especially alone.

Hair cortisol analysis shows sweat affects cortisol levels, and severe OSA may increase stress, but CPAP treatment doesn't significantly reduce physiological stress.

A new method can quickly and accurately detect drugs in hair.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The IBHRS is now operational.

Most non-medical students at Tarumanagara University have good knowledge and attitudes about PCOS.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and hormonal therapy.

A hidden autoimmune syndrome was found during a shock, showing thyroid, adrenal, and ovarian issues.